Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer

Özet

Açıklama

Alıntı

Koleksiyonlar

Endorsement

Review

Supplemented By

Referenced By